A detailed history of Sei Investments CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sei Investments CO holds 29,803 shares of REGN stock, worth $21.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
29,803
Previous 24,944 19.48%
Holding current value
$21.3 Million
Previous $26.2 Million 19.51%
% of portfolio
0.04%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $4.98 Million - $5.84 Million
4,859 Added 19.48%
29,803 $31.3 Million
Q2 2024

Aug 13, 2024

BUY
$883.2 - $1071.19 $474,278 - $575,229
537 Added 2.2%
24,944 $26.2 Million
Q1 2024

May 07, 2024

BUY
$902.69 - $993.35 $1.66 Million - $1.83 Million
1,839 Added 8.15%
24,407 $23.5 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $1.89 Million - $2.15 Million
2,440 Added 12.12%
22,568 $19.8 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $564,346 - $688,161
-815 Reduced 3.89%
20,128 $16.6 Million
Q2 2023

Aug 11, 2023

SELL
$700.03 - $830.35 $4.83 Million - $5.73 Million
-6,899 Reduced 24.78%
20,943 $15 Million
Q1 2023

May 12, 2023

SELL
$680.49 - $826.97 $2.22 Million - $2.7 Million
-3,268 Reduced 10.5%
27,842 $22.9 Million
Q4 2022

Feb 10, 2023

SELL
$705.89 - $766.39 $577,418 - $626,907
-818 Reduced 2.56%
31,110 $22.4 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $1.87 Million - $2.35 Million
3,251 Added 11.34%
31,928 $22 Million
Q2 2022

Aug 15, 2022

BUY
$548.35 - $738.84 $1.55 Million - $2.09 Million
2,834 Added 10.97%
28,677 $17 Million
Q1 2022

May 13, 2022

SELL
$595.12 - $698.43 $8.4 Million - $9.86 Million
-14,114 Reduced 35.32%
25,843 $18 Million
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $3.44 Million - $4.24 Million
6,326 Added 18.81%
39,957 $25.4 Million
Q3 2021

Nov 12, 2021

SELL
$574.03 - $680.96 $650,950 - $772,208
-1,134 Reduced 3.26%
33,631 $20.5 Million
Q2 2021

Aug 06, 2021

BUY
$472.8 - $558.54 $2.07 Million - $2.44 Million
4,376 Added 14.4%
34,765 $19.6 Million
Q1 2021

May 12, 2021

SELL
$446.73 - $548.2 $1.91 Million - $2.34 Million
-4,277 Reduced 12.34%
30,389 $14.3 Million
Q4 2020

Feb 08, 2021

BUY
$478.3 - $607.98 $1.28 Million - $1.62 Million
2,666 Added 8.33%
34,666 $16.5 Million
Q3 2020

Dec 04, 2020

SELL
$544.75 - $658.21 $614,478 - $742,460
-1,128 Reduced 3.4%
32,000 $18 Million
Q3 2020

Nov 06, 2020

BUY
$544.75 - $658.21 $4.8 Million - $5.79 Million
8,804 Added 36.19%
33,128 $18.7 Million
Q2 2020

Aug 17, 2020

BUY
$493.32 - $643.92 $471,120 - $614,943
955 Added 4.09%
24,324 $15.2 Million
Q2 2020

Aug 11, 2020

SELL
$493.32 - $643.92 $1.68 Million - $2.19 Million
-3,396 Reduced 12.69%
23,369 $9.83 Million
Q1 2020

May 14, 2020

BUY
$336.18 - $494.43 $1.46 Million - $2.14 Million
4,333 Added 19.32%
26,765 $12.9 Million
Q4 2019

Feb 06, 2020

SELL
$274.13 - $376.51 $131,856 - $181,101
-481 Reduced 2.1%
22,432 $8.47 Million
Q3 2019

Nov 12, 2019

SELL
$273.46 - $318.39 $887,377 - $1.03 Million
-3,245 Reduced 12.41%
22,913 $6.37 Million
Q2 2019

Aug 14, 2019

BUY
$299.6 - $414.82 $577,329 - $799,358
1,927 Added 7.95%
26,158 $8.19 Million
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $3.34 Million - $3.95 Million
8,990 Added 58.99%
24,231 $9.95 Million
Q3 2018

Nov 08, 2018

SELL
$351.14 - $408.51 $1.6 Million - $1.86 Million
-4,560 Reduced 23.03%
15,241 $6.16 Million
Q2 2018

Aug 03, 2018

SELL
$284.6 - $344.99 $3.08 Million - $3.73 Million
-10,808 Reduced 35.31%
19,801 $6.83 Million
Q1 2018

May 11, 2018

SELL
$315.82 - $393.78 $44.1 Million - $55 Million
-139,728 Reduced 82.03%
30,609 $10.5 Million
Q4 2017

Feb 08, 2018

SELL
$358.63 - $469.95 $5.13 Million - $6.72 Million
-14,300 Reduced 7.74%
170,337 $64 Million
Q3 2017

Nov 06, 2017

BUY
$431.38 - $504.0 $79.6 Million - $93.1 Million
184,637
184,637 $82.6 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.